Siegall Clay B

President and CEO, DirectorImmunome Inc. (IMNM) · full profile →Form 4 · filed Mar 31, 2026
Net Buying
Open-Market Buys
$501K
Open-Market Sells
$0
Net Open-Market Flow
$501K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 27, 2026Buy(P)25K$19.67$501K691K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001167496-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly: